TNFA TNF Pharmaceuticals Inc.: יחס שווי פעילות לרווח לפני ריבית, מסים ופחת

TNF Pharmaceuticals (TNFA) relies on a virtual business model, outsourcing compound synthesis and clinical trials to external partners. The company develops advanced methods to combat cellular senescence to increase healthy longevity. This EV/EBITDA valuation chart is fixed at , while the business updates its development portfolio by repurposing legacy anti-inflammatory drugs for geriatric needs.
פילוחי מדדים מקיפים ואנליטיקה עבור tnfpharma.com (TNFA)

The market values the capitalization of TNF Pharmaceuticals (TNFA) through the lens of its development efficiency in targeted therapy. The company's EV/EBITDA ratio on this chart compares the total enterprise value, including debt, with operating profit before interest, taxes, depreciation, and amortization, determining the asset payback period. The decline of this indicator amid the implementation of innovative treatments for autoimmune diseases confirms the issuer's fundamental undervaluation and financial stability.